StonvexLoading…
StonvexStonvexStonvexCore line items from MCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.72B | $7.09B | $5.92B | $5.47B |
Operating Income | $3.35B | $2.88B | $2.14B | $1.88B |
Net Income | $2.46B | $2.06B | $1.61B | $1.37B |
EPS (Diluted) | $13.67 | $11.26 | $8.73 | $7.44 |
Total Assets | $15.83B | $15.51B | $14.62B | $14.35B |
Total Liabilities | $11.63B | $11.78B | $11.15B | $11.66B |
Cash & Equivalents | $2.38B | $2.41B | $2.13B | $1.77B |
Free Cash Flow OCF − CapEx | $2.58B | $2.52B | $1.88B | $1.19B |
Shares Outstanding | 179.90M | 182.70M | 184.00M | 184.70M |